Get startedLog in
    Picture of JW (Cayman) Therapeutics Co logo

    2126 — JW (Cayman) Therapeutics Co News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    All News

    Brief: JW (Cayman) Therapeutics Posts IFRS Revenue Of RMB173.9 Mln For Year

    Picture of JW (Cayman) Therapeutics Co logoJW (Cayman) Therapeutics Co
    20/03/2024 10:32
    March 20 (Reuters) - JW (Cayman) Therapeutics Co Ltd
 2126.HK :
    * IFRS REVENUE RMB173.9 MILLION FOR YEAR, INCREASE OF 19.3%
    * FY LOSS RMB768.0 MILLION VERSUS LOSS RMB846.1 MILLION

Further company coverage:  2126.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on JW (Cayman) Therapeutics Co

    See all news